Molecular Dynamics: New Frontier in Personalized Medicine.

The field of drug discovery has witnessed infinite development over the last decade with the demand for discovery of novel efficient lead compounds. Although the development of novel compounds in this field has seen large failure, a breakthrough in this area might be the establishment of personalized medicine. The trend of personalized medicine has shown stupendous growth being a hot topic after the successful completion of Human Genome Project and 1000 genomes pilot project. Genomic variant such as SNPs play a vital role with respect to inter individual's disease susceptibility and drug response. Hence, identification of such genetic variants has to be performed before administration of a drug. This process requires high-end techniques to understand the complexity of the molecules which might bring an insight to understand the compounds at their molecular level. To sustenance this, field of bioinformatics plays a crucial role in revealing the molecular mechanism of the mutation and thereby designing a drug for an individual in fast and affordable manner. High-end computational methods, such as molecular dynamics (MD) simulation has proved to be a constitutive approach to detecting the minor changes associated with an SNP for better understanding of the structural and functional relationship. The parameters used in molecular dynamic simulation elucidate different properties of a macromolecule, such as protein stability and flexibility. MD along with docking analysis can reveal the synergetic effect of an SNP in protein-ligand interaction and provides a foundation for designing a particular drug molecule for an individual. This compelling application of computational power and the advent of other technologies have paved a promising way toward personalized medicine. In this in-depth review, we tried to highlight the different wings of MD toward personalized medicine.

[1]  G. C,et al.  Structural signature of the G719S-T790M double mutation in the EGFR kinase domain and its response to inhibitors , 2014, Scientific Reports.

[2]  Shichen Wang,et al.  Molecular Dynamics Analysis Reveals Structural Insights into Mechanism of Nicotine N-Demethylation Catalyzed by Tobacco Cytochrome P450 Mono-Oxygenase , 2011, PloS one.

[3]  B. Rannala,et al.  The Functional Significance of Common Polymorphisms in Zinc Finger Transcription Factors , 2014, G3: Genes, Genomes, Genetics.

[4]  Campbell McInnes,et al.  Virtual screening strategies in drug discovery. , 2007, Current opinion in chemical biology.

[5]  Vijay S Pande,et al.  Protein folding under confinement: A role for solvent , 2007, Proceedings of the National Academy of Sciences.

[6]  Alexander D. MacKerell,et al.  Combined ab initio/empirical approach for optimization of Lennard–Jones parameters , 1998 .

[7]  Michal Otyepka,et al.  Flexibility of human cytochrome P450 enzymes: molecular dynamics and spectroscopy reveal important function-related variations. , 2011, Biochimica et biophysica acta.

[8]  R. Marais,et al.  A personalised medicine approach for ponatinib-resistant chronic myeloid leukaemia , 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

[9]  Dimitrios Vlachakis,et al.  Gromita: A Fully Integrated Graphical User Interface to Gromacs 4 , 2009, Bioinformatics and biology insights.

[10]  J. Park,et al.  A functional polymorphism in the pre-microRNA-196a2 and the risk of lung cancer in a Korean population. , 2010, Lung cancer.

[11]  F. Lombardo,et al.  Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings , 1997 .

[12]  Molecular Dynamics Simulation Study for Ionic Strength Dependence of RNA-host factor Interaction in Staphylococcus aureus Hfq , 2010 .

[13]  Andersen,et al.  Molecular-dynamics simulation of amorphous germanium. , 1986, Physical review. B, Condensed matter.

[14]  Yubao Cui,et al.  Molecular Dynamics Simulation and Bioinformatics Study on Yeast Aquaporin Aqy1 from Pichia pastoris , 2012, International journal of biological sciences.

[15]  Dmitrij Frishman,et al.  STRIDE: a web server for secondary structure assignment from known atomic coordinates of proteins , 2004, Nucleic Acids Res..

[16]  Jacob D. Durrant,et al.  Molecular dynamics simulations and drug discovery , 2011, BMC Biology.

[17]  David E. Shaw,et al.  The future of molecular dynamics simulations in drug discovery , 2011, Journal of Computer-Aided Molecular Design.

[18]  Wei Zhang,et al.  A functional polymorphism in Pre‐miR‐146a gene is associated with prostate cancer risk and mature miR‐146a expression in vivo , 2010, The Prostate.

[19]  J. R. Grigera,et al.  The behavior of the hydrophobic effect under pressure and protein denaturation. , 2010, Biophysical journal.

[20]  Robert V. Swift,et al.  Rational Prediction with Molecular Dynamics for Hit Identification , 2012, Current topics in medicinal chemistry.

[21]  J. Maxa,et al.  Drug Interactions Due to Cytochrome P450 , 2000, Proceedings.

[22]  B. Maigret,et al.  New Binding Site Conformations of the Dengue Virus NS3 Protease Accessed by Molecular Dynamics Simulation , 2013, PloS one.

[23]  M. Gerstein,et al.  Conformational changes associated with protein-protein interactions. , 2004, Current opinion in structural biology.

[24]  D. Frenkel,et al.  Molecular dynamics simulations. , 2002, Current opinion in structural biology.

[25]  Zeming Chen,et al.  Specifically targeted delivery of protein to phagocytic macrophages , 2015, International journal of nanomedicine.

[26]  Stephen Neidle,et al.  Molecular Dynamics Studies of the STAT3 Homodimer: DNA Complex: Relationships between STAT3 Mutations and Protein-DNA Recognition , 2012, J. Chem. Inf. Model..

[27]  D. Case,et al.  Constant pH molecular dynamics in generalized Born implicit solvent , 2004, J. Comput. Chem..

[28]  D. Case,et al.  Exploring protein native states and large‐scale conformational changes with a modified generalized born model , 2004, Proteins.

[29]  T. Halgren MMFF VII. Characterization of MMFF94, MMFF94s, and other widely available force fields for conformational energies and for intermolecular‐interaction energies and geometries , 1999, Journal of computational chemistry.

[30]  Delivering preventive, predictive and personalised cancer medicine for renal cell carcinoma: the challenge of tumour heterogeneity , 2011, EPMA Journal.

[31]  Ioan Andricioaei,et al.  On the calculation of entropy from covariance matrices of the atomic fluctuations , 2001 .

[32]  J. Mccammon,et al.  HIV‐1 protease molecular dynamics of a wild‐type and of the V82F/I84V mutant: Possible contributions to drug resistance and a potential new target site for drugs , 2004, Protein science : a publication of the Protein Society.

[33]  T. Hankemeier,et al.  Metabolomics-based systems biology and personalized medicine: moving towards n = 1 clinical trials? , 2006, Pharmacogenomics.

[34]  Benjamin G. Levine,et al.  Ab initio molecular dynamics of excited-state intramolecular proton transfer using multireference perturbation theory. , 2007, The journal of physical chemistry. A.

[35]  M. Karplus,et al.  CHARMM: A program for macromolecular energy, minimization, and dynamics calculations , 1983 .

[36]  Dhavendra Kumar,et al.  Genomic medicine: a new frontier of medicine in the twenty first century , 2007, Genomic Medicine.

[37]  I. Koh,et al.  Drug to SNP: A Pharmacogenomics Database for Linking Drug Response to SNPs , 2001 .

[38]  Philip E. Bourne,et al.  Con-Struct Map: a comparative contact map analysis tool , 2007, Bioinform..

[39]  R. Hilgenfeld,et al.  Utility of homology models in the drug discovery process , 2004, Drug Discovery Today.

[40]  David S Wishart,et al.  A simple method to predict protein flexibility using secondary chemical shifts. , 2005, Journal of the American Chemical Society.

[41]  Peter M. Kasson,et al.  GROMACS 4.5: a high-throughput and highly parallel open source molecular simulation toolkit , 2013, Bioinform..

[42]  Wei Zhang,et al.  A functional polymorphism in MSMB gene promoter is associated with prostate cancer risk and serum MSMB expression , 2010, The Prostate.

[43]  M. Levitt,et al.  Potential energy function and parameters for simulations of the molecular dynamics of proteins and nucleic acids in solution , 1995 .

[44]  R. Brüschweiler,et al.  Quantitative molecular ensemble interpretation of NMR dipolar couplings without restraints. , 2007, Journal of the American Chemical Society.

[45]  A. Gronenborn,et al.  Determination of three‐dimensional structures of proteins from interproton distance data by dynamical simulated annealing from a random array of atoms Circumventing problems associated with folding , 1988, FEBS letters.

[46]  Mark Kroese,et al.  'Personalized medicine': what's in a name? , 2014, Personalized medicine.

[47]  Peng Yang,et al.  Modeling, Molecular Dynamics Simulation, and Mutation Validation for Structure of Cannabinoid Receptor 2 Based on Known Crystal Structures of GPCRs , 2014, J. Chem. Inf. Model..

[48]  Michal Otyepka,et al.  Flexibility of human cytochromes P450: molecular dynamics reveals differences between CYPs 3A4, 2C9, and 2A6, which correlate with their substrate preferences. , 2008, The journal of physical chemistry. B.

[49]  Luonan Chen,et al.  Extrapolating the effect of deleterious nsSNPs in the binding adaptability of flavopiridol with CDK7 protein: a molecular dynamics approach , 2013, Human Genomics.

[50]  C. Brooks,et al.  Recent advances in the development and application of implicit solvent models in biomolecule simulations. , 2004, Current opinion in structural biology.

[51]  M. Oscarson Pharmacogenetics of Drug Metabolising Enzymes: Importance for Personalised Medicine , 2003, Clinical chemistry and laboratory medicine.

[52]  Gert Vriend,et al.  Making optimal use of empirical energy functions: Force‐field parameterization in crystal space , 2004, Proteins.

[53]  Taehoon Kim,et al.  CHARMM‐GUI: A web‐based graphical user interface for CHARMM , 2008, J. Comput. Chem..

[54]  W. L. Jorgensen,et al.  The OPLS [optimized potentials for liquid simulations] potential functions for proteins, energy minimizations for crystals of cyclic peptides and crambin. , 1988, Journal of the American Chemical Society.

[55]  Amedeo Caflisch,et al.  The Free Energy Landscape of Small Molecule Unbinding , 2011, PLoS Comput. Biol..

[56]  Emmanuel Barillot,et al.  Bioinformatics for precision medicine in oncology: principles and application to the SHIVA clinical trial , 2014, Front. Genet..

[57]  Andrew D. Johnson,et al.  Multidrug resistance polypeptide 1 (MDR1, ABCB1) variant 3435C>T affects mRNA stability , 2005, Pharmacogenetics and genomics.

[58]  Laxmikant V. Kale,et al.  NAMD2: Greater Scalability for Parallel Molecular Dynamics , 1999 .

[59]  V. Acharya,et al.  Hansa: An automated method for discriminating disease and neutral human nsSNPs , 2012, Human mutation.

[60]  Torsten Schwede,et al.  Automated comparative protein structure modeling with SWISS‐MODEL and Swiss‐PdbViewer: A historical perspective , 2009, Electrophoresis.

[61]  Tariq Ahmad Masoodi,et al.  In silico analysis of Single Nucleotide Polymorphisms (SNPs) in human BRAF gene. , 2012, Gene.

[62]  Alexander D. MacKerell,et al.  Comparison of protein force fields for molecular dynamics simulations. , 2008, Methods in molecular biology.

[63]  Paul D Lyne,et al.  Structure-based virtual screening: an overview. , 2002, Drug discovery today.

[64]  C. Swanton,et al.  Tumour heterogeneity and drug resistance: personalising cancer medicine through functional genomics. , 2012, Biochemical pharmacology.

[65]  A. Lang,et al.  Response to clozapine in a clinically identifiable subtype of schizophrenia. , 2015, The British journal of psychiatry : the journal of mental science.

[66]  Marialva Sinigaglia,et al.  New Insights into the In Silico Prediction of HIV Protease Resistance to Nelfinavir , 2014, PloS one.

[67]  M. Orozco,et al.  Cooperativity in drug-DNA recognition: a molecular dynamics study. , 2001, Journal of the American Chemical Society.

[68]  C. George Priya Doss,et al.  Computational Refinement of Functional Single Nucleotide Polymorphisms Associated with ATM Gene , 2012, PloS one.

[69]  K Schulten,et al.  VMD: visual molecular dynamics. , 1996, Journal of molecular graphics.

[70]  M. Ducreux,et al.  Targeted therapy in metastatic colorectal cancer -- an example of personalised medicine in action. , 2013, Cancer treatment reviews.

[71]  A. Mark,et al.  Mechanism by which 2,2,2-trifluoroethanol/water mixtures stabilize secondary-structure formation in peptides: A molecular dynamics study , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[72]  A. Caflisch,et al.  Molecular dynamics in drug design. , 2015, European journal of medicinal chemistry.

[73]  Wei Zhang,et al.  In Silico Discovery of Potential VEGFR-2 Inhibitors from Natural Derivatives for Anti-Angiogenesis Therapy , 2014, International journal of molecular sciences.

[74]  Laxmikant V. Kalé,et al.  Scalable molecular dynamics with NAMD , 2005, J. Comput. Chem..

[75]  Zahra Karimi,et al.  VMD DisRg: New User-Friendly Implement for calculation distance and radius of gyration in VMD program , 2012, Bioinformation.

[76]  Euan A Ashley,et al.  Personalized medicine: hope or hype? , 2012, European heart journal.

[77]  S. Teague Implications of protein flexibility for drug discovery , 2003, Nature Reviews Drug Discovery.

[78]  Steven Henikoff,et al.  SIFT: predicting amino acid changes that affect protein function , 2003, Nucleic Acids Res..

[79]  J. Ponder,et al.  Force fields for protein simulations. , 2003, Advances in protein chemistry.

[80]  L. Lewis Personalized drug therapy; the genome, the chip and the physician. , 2005, British journal of clinical pharmacology.

[81]  G. Klebe,et al.  Approaches to the description and prediction of the binding affinity of small-molecule ligands to macromolecular receptors. , 2002, Angewandte Chemie.

[82]  D. Tobias,et al.  Electrostatic interactions and hydrogen bond dynamics in chloride pumping by halorhodopsin. , 2014, Biochimica et biophysica acta.

[83]  D Peter Tieleman,et al.  Molecular dynamics simulation of spontaneous membrane fusion during a cubic-hexagonal phase transition. , 2002, Biophysical journal.

[84]  Maxim Dolgushev,et al.  Dynamics of semiflexible scale-free polymer networks. , 2014, The Journal of chemical physics.

[85]  Predrag Radivojac,et al.  Automated inference of molecular mechanisms of disease from amino acid substitutions , 2009, Bioinform..

[86]  R. Altman,et al.  WS-SNPs&GO: a web server for predicting the deleterious effect of human protein variants using functional annotation , 2013, BMC Genomics.

[87]  R. Kream,et al.  Personalized- and One- Medicine: Bioinformatics Foundation in Health and its Economic Feasibility , 2015, Medical science monitor : international medical journal of experimental and clinical research.

[88]  Pramod Katara,et al.  Role of bioinformatics and pharmacogenomics in drug discovery and development process , 2013, Network Modeling Analysis in Health Informatics and Bioinformatics.

[89]  C. George Priya Doss,et al.  A New Insight into Structural and Functional Impact of Single-Nucleotide Polymorphisms in PTEN Gene , 2013, Cell Biochemistry and Biophysics.

[90]  R. Gargallo,et al.  Effect of the reaction field electrostatic term on the molecular dynamics simulation of the activation domain of procarboxypeptidase B. , 2000, Protein engineering.

[91]  Cheng-I Weng,et al.  Three-dimensional molecular dynamics analysis of processing using a pin tool on the atomic scale , 2000 .

[92]  Wei Zhang,et al.  A point‐charge force field for molecular mechanics simulations of proteins based on condensed‐phase quantum mechanical calculations , 2003, J. Comput. Chem..

[93]  Charlotte M. Deane,et al.  Gro2mat: A package to efficiently read gromacs output in MATLAB , 2014, J. Comput. Chem..

[94]  Yang Zhang,et al.  I-TASSER server for protein 3D structure prediction , 2008, BMC Bioinformatics.

[95]  Paul Sharratt,et al.  Molecular dynamics methodology for the study of the solvent effects on a concentrated Diels-Alder reaction and the separation of the post-reaction mixture , 1998 .

[96]  A. Kolesnikov,et al.  Coarse-grained model of glycosaminoglycans in aqueous salt solutions. A field-theoretical approach. , 2014, The journal of physical chemistry. B.

[97]  B. Shastry,et al.  Pharmacogenetics and the concept of individualized medicine , 2006, The Pharmacogenomics Journal.

[98]  R B Altman,et al.  The Pharmacogenetics Research Network: From SNP Discovery to Clinical Drug Response , 2007, Clinical pharmacology and therapeutics.

[99]  Pradeep Kota GUIMACS - A Java Based Front End for GROMACS , 2007, Silico Biol..

[100]  M. Sansom,et al.  How Does a Voltage Sensor Interact with a Lipid Bilayer? Simulations of a Potassium Channel Domain , 2007, Structure.

[101]  C. George Priya Doss,et al.  Computational Methods to Work as First-Pass Filter in Deleterious SNP Analysis of Alkaptonuria , 2012, TheScientificWorldJournal.

[102]  Adrian H Elcock,et al.  Computational sampling of a cryptic drug binding site in a protein receptor: explicit solvent molecular dynamics and inhibitor docking to p38 MAP kinase. , 2006, Journal of molecular biology.

[103]  Xiaowei Yang,et al.  Towards Structural Systems Pharmacology to Study Complex Diseases and Personalized Medicine , 2014, PLoS Comput. Biol..

[104]  Andrew D. Johnson,et al.  Polymorphisms affecting gene regulation and mRNA processing: broad implications for pharmacogenetics. , 2005, Pharmacology & therapeutics.

[105]  E. Vauthey,et al.  Molecular dynamics simulations of liquid phase interfaces: understanding the structure of the glycerol/water-dodecane system. , 2013, Langmuir : the ACS journal of surfaces and colloids.

[106]  U. Singh,et al.  A NEW FORCE FIELD FOR MOLECULAR MECHANICAL SIMULATION OF NUCLEIC ACIDS AND PROTEINS , 1984 .

[107]  Emil Alexov,et al.  Advances in Human Biology: Combining Genetics and Molecular Biophysics to Pave the Way for Personalized Diagnostics and Medicine , 2014 .

[108]  Jahan B. Ghasemi,et al.  Combined docking, molecular dynamics simulations and spectroscopic studies for the rational design of a dipeptide ligand for affinity chromatography separation of human serum albumin , 2014, Journal of Molecular Modeling.

[109]  César Augusto F. de Oliveira,et al.  Coupling Constant pH Molecular Dynamics with Accelerated Molecular Dynamics , 2010, Journal of chemical theory and computation.

[110]  P. Ruitenbeek,et al.  Histamine H1 receptor antagonist cetirizine impairs working memory processing speed, but not episodic memory , 2010, British journal of pharmacology.

[111]  Robin D Couch,et al.  Personalized medicine: changing the paradigm of drug development. , 2012, Methods in molecular biology.

[112]  A. Y. Lu,et al.  Pharmacogenetics, Pharmacogenomics, and Individualized Medicine , 2011, Pharmacological Reviews.

[113]  Munir Pirmohamed,et al.  Personalized pharmacogenomics: predicting efficacy and adverse drug reactions. , 2014, Annual review of genomics and human genetics.

[114]  C. Doss,et al.  Investigating the Structural Impacts of I64T and P311S Mutations in APE1-DNA Complex: A Molecular Dynamics Approach , 2012, PloS one.

[115]  Toshikazu Ebisuzaki,et al.  A smooth‐particle mesh Ewald method for DL_POLY molecular dynamics simulation package on the Fujitsu VPP700 , 2000 .

[116]  O. V. Galzitskaya,et al.  Radius of gyration as an indicator of protein structure compactness , 2008, Molecular Biology.

[117]  R. Iida,et al.  Genetic and expression analysis of SNPs in the human deoxyribonuclease II: SNPs in the promoter region reduce its in vivo activity through decreased promoter activity , 2012, Electrophoresis.

[118]  S. Peng,et al.  Association of MicroRNA-196a-2 Gene Polymorphism with Gastric Cancer Risk in a Chinese Population , 2010, Digestive Diseases and Sciences.

[119]  M. Steinbach,et al.  High-Order SNP Combinations Associated with Complex Diseases: Efficient Discovery, Statistical Power and Functional Interactions , 2012, PloS one.

[120]  Hugh S Markus,et al.  Personalized medicine: risk prediction, targeted therapies and mobile health technology , 2014, BMC Medicine.

[121]  Markus Christen,et al.  The GROMOS software for biomolecular simulation: GROMOS05 , 2005, J. Comput. Chem..

[122]  Yuxiang Yan,et al.  Traditional Chinese medicine and new concepts of predictive, preventive and personalized medicine in diagnosis and treatment of suboptimal health , 2014, EPMA Journal.

[123]  Bert L. de Groot,et al.  Conformational Transitions upon Ligand Binding: Holo-Structure Prediction from Apo Conformations , 2010, PLoS Comput. Biol..

[124]  J. Åqvist,et al.  Ligand binding affinities from MD simulations. , 2002, Accounts of chemical research.

[125]  Paolo Tosco,et al.  Bringing the MMFF force field to the RDKit: implementation and validation , 2014, Journal of Cheminformatics.

[126]  W E Moerner,et al.  Principal-components analysis of shape fluctuations of single DNA molecules , 2007, Proceedings of the National Academy of Sciences.

[127]  David P Lane,et al.  Molecular simulations of protein dynamics: new windows on mechanisms in biology , 2008, EMBO reports.

[128]  A. V. Popov,et al.  GUI-BioPASED: A program for molecular dynamics simulations of biopolymers with a graphical user interface , 2010, Molecular Biology.

[129]  M. Tashiro,et al.  Roles of histamine in regulation of arousal and cognition: functional neuroimaging of histamine H1 receptors in human brain. , 2002, Life sciences.

[130]  Thomas Simonson,et al.  Molecular Dynamics Simulations Show That Conformational Selection Governs the Binding Preferences of Imatinib for Several Tyrosine Kinases* , 2010, The Journal of Biological Chemistry.

[131]  Seth I. Berger,et al.  Role of systems pharmacology in understanding drug adverse events , 2011, Wiley interdisciplinary reviews. Systems biology and medicine.

[132]  S. H. Chen,et al.  Neutron structure factors of in-vivo deuterated amorphous protein C-phycocyanin. , 1993, Biophysical journal.

[133]  J Andrew McCammon,et al.  HBonanza: a computer algorithm for molecular-dynamics-trajectory hydrogen-bond analysis. , 2011, Journal of molecular graphics & modelling.

[134]  A. Laaksonen,et al.  Molecular dynamics simulation and NMR study of water-acetonitrile mixtures , 1991 .

[135]  M Vendruscolo,et al.  Recovery of protein structure from contact maps. , 1997, Folding & design.

[136]  Jaroslav Bendl,et al.  PredictSNP: Robust and Accurate Consensus Classifier for Prediction of Disease-Related Mutations , 2014, PLoS Comput. Biol..

[137]  Luonan Chen,et al.  Integrating In Silico Prediction Methods, Molecular Docking, and Molecular Dynamics Simulation to Predict the Impact of ALK Missense Mutations in Structural Perspective , 2014, BioMed research international.

[138]  Aleksey A. Porollo,et al.  POLYVIEW-MM: web-based platform for animation and analysis of molecular simulations , 2010, Nucleic Acids Res..

[139]  Lin Wang,et al.  Analyzing Effects of Naturally Occurring Missense Mutations , 2012, Comput. Math. Methods Medicine.

[140]  R. Friesner,et al.  Evaluation and Reparametrization of the OPLS-AA Force Field for Proteins via Comparison with Accurate Quantum Chemical Calculations on Peptides† , 2001 .

[141]  Andrea Amadei,et al.  Molecular dynamics simulation of protein folding by essential dynamics sampling: folding landscape of horse heart cytochrome c. , 2003, Biophysical journal.

[142]  N. Subbarao,et al.  In Silico Screening, Genotyping, Molecular Dynamics Simulation and Activity Studies of SNPs in Pyruvate Kinase M2 , 2015, PloS one.

[143]  T. Darden,et al.  Molecular dynamics simulations of biomolecules: long-range electrostatic effects. , 1999, Annual review of biophysics and biomolecular structure.

[144]  Yury N. Vorobjev,et al.  MDTRA: A molecular dynamics trajectory analyzer with a graphical user interface , 2013, J. Comput. Chem..

[145]  Holger Gohlke,et al.  NMSim Web Server: integrated approach for normal mode-based geometric simulations of biologically relevant conformational transitions in proteins , 2012, Nucleic Acids Res..

[146]  Peter A. Kollman,et al.  AMBER: Assisted model building with energy refinement. A general program for modeling molecules and their interactions , 1981 .

[147]  I. Adzhubei,et al.  Predicting Functional Effect of Human Missense Mutations Using PolyPhen‐2 , 2013, Current protocols in human genetics.

[148]  Bin Zhou,et al.  Common genetic polymorphisms in pre‐microRNAs and risk of cervical squamous cell carcinoma , 2011, Molecular carcinogenesis.

[149]  U. Meyer Pharmacogenetics and adverse drug reactions , 2000, The Lancet.

[150]  W. Gmeiner,et al.  Molecular dynamics simulation of the human U2B" protein complex with U2 snRNA hairpin IV in aqueous solution. , 2001, Biophysical journal.

[151]  Makoto Taiji,et al.  High-Performance Drug Discovery: Computational Screening by Combining Docking and Molecular Dynamics Simulations , 2009, PLoS Comput. Biol..

[152]  Pavel Hobza,et al.  Molecular dynamics simulations and thermodynamics analysis of DNA-drug complexes. Minor groove binding between 4',6-diamidino-2-phenylindole and DNA duplexes in solution. , 2003, Journal of the American Chemical Society.

[153]  W. L. Jorgensen,et al.  Development and Testing of the OPLS All-Atom Force Field on Conformational Energetics and Properties of Organic Liquids , 1996 .

[154]  Supot Hannongbua,et al.  Structure, Dynamics and Solvation of HIV-1 Protease/Saquinavir Complex in Aqueous Solution and Their Contributions to Drug Resistance: Molecular Dynamic Simulations , 2005, J. Chem. Inf. Model..

[155]  G. Ginsburg,et al.  Personalized medicine: revolutionizing drug discovery and patient care. , 2001, Trends in biotechnology.

[156]  E. Copson,et al.  Clinical proteomics and breast cancer. , 2015, The surgeon : journal of the Royal Colleges of Surgeons of Edinburgh and Ireland.

[157]  Jin Qin,et al.  Molecular Dynamics Simulation, Free Energy Calculation and Structure-Based 3D-QSAR Studies of B-RAF Kinase Inhibitors , 2011, J. Chem. Inf. Model..

[158]  Yuichi Sugiyama,et al.  Impact of Drug Transporter Studies on Drug Discovery and Development , 2003, Pharmacological Reviews.

[159]  C. Flück,et al.  Reduction in hepatic drug metabolizing CYP3A4 activities caused by P450 oxidoreductase mutations identified in patients with disordered steroid metabolism. , 2010, Biochemical and biophysical research communications.

[160]  Helmut Grubmüller,et al.  Keep It Flexible: Driving Macromolecular Rotary Motions in Atomistic Simulations with GROMACS , 2011, Journal of chemical theory and computation.

[161]  Ruth Nussinov,et al.  Structure and dynamics of molecular networks: A novel paradigm of drug discovery. A comprehensive review , 2012, Pharmacology & therapeutics.

[162]  N. Guex,et al.  SWISS‐MODEL and the Swiss‐Pdb Viewer: An environment for comparative protein modeling , 1997, Electrophoresis.

[163]  M. Gillard,et al.  Binding characteristics of cetirizine and levocetirizine to human H(1) histamine receptors: contribution of Lys(191) and Thr(194). , 2002, Molecular pharmacology.

[164]  Rajendra Kumar,et al.  g_mmpbsa - A GROMACS Tool for High-Throughput MM-PBSA Calculations , 2014, J. Chem. Inf. Model..

[165]  Donghui Li,et al.  Single Nucleotide Polymorphisms of Gemcitabine Metabolic Genes and Pancreatic Cancer Survival and Drug Toxicity , 2009, Clinical Cancer Research.

[166]  Burkhard Rost,et al.  DSSPcont: continuous secondary structure assignments for proteins , 2003, Nucleic Acids Res..

[167]  Guohui Li,et al.  Advancement of polarizable force field and its use for molecular modeling and design. , 2015, Advances in experimental medicine and biology.

[168]  Alan L Harvey,et al.  Natural products in drug discovery. , 2008, Drug discovery today.

[169]  Yang Song,et al.  Therapeutic target database update 2012: a resource for facilitating target-oriented drug discovery , 2011, Nucleic Acids Res..

[170]  J. Berg,et al.  Molecular dynamics simulations of biomolecules , 2002, Nature Structural Biology.

[171]  V. Hornak,et al.  Comparison of multiple Amber force fields and development of improved protein backbone parameters , 2006, Proteins.

[172]  C. George Priya Doss,et al.  Computational approaches and resources in single amino acid substitutions analysis toward clinical research. , 2014, Advances in protein chemistry and structural biology.

[173]  P. Kollman,et al.  A Second Generation Force Field for the Simulation of Proteins, Nucleic Acids, and Organic Molecules , 1995 .

[174]  Wilfred F. van Gunsteren,et al.  An improved GROMOS96 force field for aliphatic hydrocarbons in the condensed phase , 2001, J. Comput. Chem..

[175]  T. Halgren Merck molecular force field. II. MMFF94 van der Waals and electrostatic parameters for intermolecular interactions , 1996 .

[176]  N. Zhang,et al.  Structural basis for decreased affinity of Emodin binding to Val66-mutated human CK2α as determined by molecular dynamics , 2010, Journal of molecular modeling.

[177]  Vittorio Scarano,et al.  COCOMAPS: a web application to analyze and visualize contacts at the interface of biomolecular complexes , 2011, Bioinform..

[178]  Sven Frokjaer,et al.  Predicting Drug Absorption from Molecular Surface Properties Based on Molecular Dynamics Simulations , 1998, Pharmaceutical Research.

[179]  K. Schulten,et al.  Single-Molecule Experiments in Vitro and in Silico , 2007, Science.

[180]  A. Sali,et al.  Modeller: generation and refinement of homology-based protein structure models. , 2003, Methods in enzymology.

[181]  S. Derks,et al.  Personalized cancer medicine: next steps in the genomic era , 2015, Cellular Oncology.

[182]  V. Daggett,et al.  Increasing temperature accelerates protein unfolding without changing the pathway of unfolding. , 2002, Journal of molecular biology.

[183]  Sunil K. Panigrahi Strong and weak hydrogen bonds in protein-ligand complexes of kinases: a comparative study , 2008, Amino Acids.

[184]  R. Purohit,et al.  A novel computational and structural analysis of nsSNPs in CFTR gene , 2008, Genomic Medicine.

[185]  Vitaly A. Kuzkin,et al.  On angular momentum balance for particle systems with periodic boundary conditions , 2013, 1312.7008.

[186]  R. Iyengar,et al.  Systems pharmacology: network analysis to identify multiscale mechanisms of drug action. , 2012, Annual review of pharmacology and toxicology.

[187]  Vittorio Scarano,et al.  CONSRANK: a server for the analysis, comparison and ranking of docking models based on inter-residue contacts , 2015, Bioinform..

[188]  K. Winey,et al.  Polymer conformations in polymer nanocomposites containing spherical nanoparticles. , 2015, Soft matter.

[189]  T. Lybrand Ligand-protein docking and rational drug design. , 1995, Current Opinion in Structural Biology.

[190]  Dimitrios H Roukos,et al.  Individual genomes and personalized medicine: life diversity and complexity. , 2010, Personalized medicine.

[191]  Emad Tajkhorshid,et al.  Visualizing Functional Motions of Membrane Transporters with Molecular Dynamics Simulations , 2013, Biochemistry.

[192]  Chris Oostenbrink,et al.  A biomolecular force field based on the free enthalpy of hydration and solvation: The GROMOS force‐field parameter sets 53A5 and 53A6 , 2004, J. Comput. Chem..

[193]  J. Smith,et al.  Derivation of a molecular mechanics force field for cholesterol , 2004 .

[194]  Indra Neil Sarkar,et al.  Bioinformatics opportunities for identification and study of medicinal plants , 2013, Briefings Bioinform..

[195]  Ivet Bahar,et al.  Principal component analysis of native ensembles of biomolecular structures (PCA_NEST): insights into functional dynamics , 2009, Bioinform..

[196]  Sabine C. Mueller,et al.  BALL-SNP: combining genetic and structural information to identify candidate non-synonymous single nucleotide polymorphisms , 2015, Genome Medicine.

[197]  C. George Priya Doss,et al.  Deciphering the impact of somatic mutations in exon 20 and exon 9 of PIK3CA gene in breast tumors among Indian women through molecular dynamics approach , 2016, Journal of biomolecular structure & dynamics.

[198]  V Maojo,et al.  Nanoinformatics knowledge infrastructures: bringing efficient information management to nanomedical research. , 2013, Computational science & discovery.

[199]  Z. Abduljaleel,et al.  In Silico Analysis of Single Nucleotide Polymorphism (SNPs) in Human β-Globin Gene , 2011, PloS one.

[200]  W. Delano The PyMOL Molecular Graphics System , 2002 .

[201]  Stewart A. Adcock,et al.  Molecular dynamics: survey of methods for simulating the activity of proteins. , 2006, Chemical reviews.

[202]  S. D. de Alencar,et al.  A Comprehensive In Silico Analysis of the Functional and Structural Impact of SNPs in the IGF1R Gene , 2010, Journal of biomedicine & biotechnology.